Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 11/2016

01-11-2016 | Correspondence

Stereotactic body radiotherapy in non-operable lung cancer patients

Authors: R. E. Vadalà, A. Santacaterina, A. Sindoni, A. Platania, A. Arcudi, G. Ferini, M. M. Mazzei, D. Marletta, C. Rifatto, E. V. I. Risoleti, C. Severo, A. Pontoriero, G. Iatì, S. Pergolizzi

Published in: Clinical and Translational Oncology | Issue 11/2016

Login to get access

Excerpt

To the Editor …
Literature
1.
Ceniceros L, Aristu J, Castañón E, Rolfo C, Legaspi J, Olarte A, et al. Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients. Clin Transl Oncol. 2016;18:259–68.CrossRefPubMed
2.
Pergolizzi S, Santacaterina A, Renzis CD, Settineri N, Gaeta M, Frosina P, et al. Older people with non small cell lung cancer in clinical stage IIIA and co-morbid conditions. Is curative irradiation feasible? Final results of a prospective study. Lung Cancer. 2002;37:201–6.CrossRefPubMed
3.
Sindoni A, Minutoli F, Pontoriero A, Iatì G, Baldari S, Pergolizzi S. Usefulness of four dimensional (4D) PET/CT imaging in the evaluation of thoracic lesions and in radiotherapy planning: review of the literature. Lung Cancer. 2016;96:78–86.CrossRefPubMed
4.
Ramella S, Maranzano E, Frata P, Mantovani C, Lazzari G, Menichelli C, et al. Radiotherapy in Italy for non-small cell lung cancer: patterns of care survey. Tumori. 2012;98:66–78.PubMed
5.
Amato E, Italiano A, Leotta S, Pergolizzi S, Torrisi L. Monte Carlo study of the dose enhancement effect of gold nanoparticles during X-ray therapies and evaluation of the anti-angiogenic effect on tumour capillary vessels. J X-ray Sci Technol. 2013;21:237–47.
6.
Amato E, Italiano A, Pergolizzi S. Gold nanoparticles as a sensitising agent in external beam radiotherapy and brachytherapy: a feasibility study through Monte Carlo simulation. Int J Nanotechnol. 2013;10:1045–54.CrossRef
Metadata
Title
Stereotactic body radiotherapy in non-operable lung cancer patients
Authors
R. E. Vadalà
A. Santacaterina
A. Sindoni
A. Platania
A. Arcudi
G. Ferini
M. M. Mazzei
D. Marletta
C. Rifatto
E. V. I. Risoleti
C. Severo
A. Pontoriero
G. Iatì
S. Pergolizzi
Publication date
01-11-2016
Publisher
Springer International Publishing
Published in
Clinical and Translational Oncology / Issue 11/2016
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-016-1552-7

Other articles of this Issue 11/2016

Clinical and Translational Oncology 11/2016 Go to the issue

Research Article

Residual neck disease management in squamous-cell carcinoma of the head and neck treated with radiotherapy plus cetuximab

Review Article

Regulation of epithelial–mesenchymal transition in endometrial cancer: connecting PI3K, estrogen signaling, and microRNAs

Research Article

The appropriate axillary procedure after a positive sentinel node in breast cancer patients: the “Hôpital Tenon” score revisited. A two-institution study

Research Article

Extreme liver surgery as treatment of liver tumors involving the hepatocaval confluence

Review Article

Is regorafenib providing clinically meaningful benefits to pretreated patients with metastatic colorectal cancer?

Research Article

Preoperative low-dose weekly cisplatin and continuous infusion fluorouracil plus hyperfractionated radiotherapy in stage II–III esophageal carcinoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits